A NEW APPROACH TO THE ADOPTIVE IMMUNOTHERAPY OF CANCER WITH TUMOR-INFILTRATING LYMPHOCYTES

[1] BELLDEGRUN A, UNPUB

[2] BERENDT MJ, 1980, J EXP MED, V151, P69, DOI 10.1084/jem.151.1.69

[3] INHIBITION OF ESTABLISHED TRANSPLANTS OF CHEMICALLY INDUCED SARCOMAS IN SYNGENEIC MICE BY LYMPHOCYTES FROM IMMUNIZED DONORS [J]. INTERNATIONAL JOURNAL OF CANCER, 1972, 10 (03) : 539 - &

[4] BRESLOW N, 1970, BIOMETRIKA, V57, P579, DOI 10.1093/biomet/57.3.579

[5] CHEEVER MA, 1980, J IMMUNOL, V125, P711

[6] ETTINGHAUSEN SE, 1985, J IMMUNOL, V135, P1488

[7] ETTINGHAUSEN SE, 1985, J IMMUNOL, V135, P3623

[8] MODELS FOR SYNGENEIC ADOPTIVE CHEMOIMMUNOTHERAPY OF MURINE LEUKEMIAS [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1976, 276 (SEP3) : 573 - 583

[9] FERNANDEZCRUZ E, 1979, J IMMUNOL, V123, P1772

[10] LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON - LYSIS OF NATURAL KILLER-RESISTANT FRESH SOLID TUMOR-CELLS BY INTERLEUKIN 2-ACTIVATED AUTOLOGOUS HUMAN PERIPHERAL-BLOOD LYMPHOCYTES [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (06) : 1823 - 1841

[1] BELLDEGRUN A, UNPUB

[2] BERENDT MJ, 1980, J EXP MED, V151, P69, DOI 10.1084/jem.151.1.69

[3] INHIBITION OF ESTABLISHED TRANSPLANTS OF CHEMICALLY INDUCED SARCOMAS IN SYNGENEIC MICE BY LYMPHOCYTES FROM IMMUNIZED DONORS [J]. INTERNATIONAL JOURNAL OF CANCER, 1972, 10 (03) : 539 - &

[4] BRESLOW N, 1970, BIOMETRIKA, V57, P579, DOI 10.1093/biomet/57.3.579

[5] CHEEVER MA, 1980, J IMMUNOL, V125, P711

[6] ETTINGHAUSEN SE, 1985, J IMMUNOL, V135, P1488

[7] ETTINGHAUSEN SE, 1985, J IMMUNOL, V135, P3623

[8] MODELS FOR SYNGENEIC ADOPTIVE CHEMOIMMUNOTHERAPY OF MURINE LEUKEMIAS [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1976, 276 (SEP3) : 573 - 583

[9] FERNANDEZCRUZ E, 1979, J IMMUNOL, V123, P1772

[10] LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON - LYSIS OF NATURAL KILLER-RESISTANT FRESH SOLID TUMOR-CELLS BY INTERLEUKIN 2-ACTIVATED AUTOLOGOUS HUMAN PERIPHERAL-BLOOD LYMPHOCYTES [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (06) : 1823 - 1841